AI assistant
NEOGENOMICS INC — Director's Dealing 2024
Feb 27, 2024
32227_dirs_2024-02-27_f1ba6099-86eb-459b-9d63-586c0f86fe4b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2024-02-23
Reporting Person: Stone Warren (President, Clinical Services)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-23 | Stock Option (Right to Buy) | $16.45 | A | 42344 | Acquired | 2034-02-23 | Common Stock (42344) | Direct |
| 2024-02-23 | Restricted Stock Unit | $0 | A | 25329 | Acquired | Common Stock (25329) | Direct | |
| 2024-02-23 | Performance Stock Unit | $0 | A | 25330 | Acquired | Common Stock (25330) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 83775 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $11.21 | 2029-12-01 | Common Stock (166113) | 166113 | Direct |
| Stock Option (Right to Buy) | $19.65 | 2030-05-11 | Common Stock (53969) | 53969 | Direct |
| Restricted Stock Unit | $0 | Common Stock (28838) | 28838 | Direct | |
| Performance Stock Unit | $0 | Common Stock (21204) | 21204 | Direct |
Footnotes
F1: On December 1, 2022, Mr. Stone was granted 166,113 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F2: On May 11, 2023, Mr. Stone was granted 53,969 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F3: On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F4: Once vested, the shares of common stock are not subject to expiration.
F5: On May 11, 2023, Mr. Stone was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
F6: On February 23, 2024, Mr. Stone was granted 42,344 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F7: On February 23, 2024, Mr. Stone was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F8: On February 23, 2024, Mr. Stone was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.